Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Renal Cell 145Kidney Neoplasms 42Prostatic Neoplasms 16Neoplasm Metastasis 16Urinary Bladder Neoplasms 13Neoplasms 9Clear-cell metastatic renal cell carcinoma 6Breast Neoplasms 5Kidney Diseases 4Carcinoma, Non-Small-Cell Lung 4Carcinoma, Hepatocellular 4Urologic Neoplasms 3Urogenital Neoplasms 3Urethral Neoplasms 3Thyroid Neoplasms 3Ovarian Neoplasms 3Multiple Myeloma 3Gastrointestinal Stromal Tumors 3Carcinoma 3Stomach Neoplasms 2Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Myeloproliferative Disorders 2Melanoma 2Lymphoma, Non-Hodgkin 2Lung Neoplasms 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2

Interventions

pazopanib 2Sunitinib 2Sorafenib 2Bevacizumab 2Surveys and Questionnaires 1Quality Indicators, Health Care 1Immunization, Secondary 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Financial Stress × Sunitinib × Genitourinary × Clear all
NCT01381601 2013-05-13

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)

GlaxoSmithKline

Completed
1 enrolled
Genitourinary

Financial Stress, Carcinoma, Renal Cell

NCT01381614 2013-05-13

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)

GlaxoSmithKline

Completed
1 enrolled
Genitourinary

Financial Stress, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡